In addition, studies have reported variations in CD117 expression in human STSs, from 0 to 20% of the cases (20, 55), and the lack of CD117 expression in leiomyosarcomas allows us to differentiate them from GISTs that are CD117 positive (56). The gene discussed is KIT; the disease is leiomyosarcoma.